Latent TB Infection Testing and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Latent TB Infection Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Latent TB Infection Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Latent TB Infection Testing Overall Market Size
2.1 Global Latent TB Infection Testing Market Size: 2021 VS 2028
2.2 Global Latent TB Infection Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Latent TB Infection Testing Players in Global Market
3.2 Top Global Latent TB Infection Testing Companies Ranked by Revenue
3.3 Global Latent TB Infection Testing Revenue by Companies
3.4 Top 3 and Top 5 Latent TB Infection Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Latent TB Infection Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Latent TB Infection Testing Players in Global Market
3.6.1 List of Global Tier 1 Latent TB Infection Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Latent TB Infection Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Latent TB Infection Testing Market Size Markets, 2021 & 2028
4.1.2 Mantoux Test / Tuberculin Skin Test (TST)
4.1.3 Interferon-Gamma Release Assay (IGRA)
4.2 By Type - Global Latent TB Infection Testing Revenue & Forecasts
4.2.1 By Type - Global Latent TB Infection Testing Revenue, 2017-2022
4.2.2 By Type - Global Latent TB Infection Testing Revenue, 2023-2028
4.2.3 By Type - Global Latent TB Infection Testing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Latent TB Infection Testing Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Public and Student Health
5.1.4 Physician Offices and Clinics
5.1.5 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
5.2 By Application - Global Latent TB Infection Testing Revenue & Forecasts
5.2.1 By Application - Global Latent TB Infection Testing Revenue, 2017-2022
5.2.2 By Application - Global Latent TB Infection Testing Revenue, 2023-2028
5.2.3 By Application - Global Latent TB Infection Testing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Latent TB Infection Testing Market Size, 2021 & 2028
6.2 By Region - Global Latent TB Infection Testing Revenue & Forecasts
6.2.1 By Region - Global Latent TB Infection Testing Revenue, 2017-2022
6.2.2 By Region - Global Latent TB Infection Testing Revenue, 2023-2028
6.2.3 By Region - Global Latent TB Infection Testing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Latent TB Infection Testing Revenue, 2017-2028
6.3.2 US Latent TB Infection Testing Market Size, 2017-2028
6.3.3 Canada Latent TB Infection Testing Market Size, 2017-2028
6.3.4 Mexico Latent TB Infection Testing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Latent TB Infection Testing Revenue, 2017-2028
6.4.2 Germany Latent TB Infection Testing Market Size, 2017-2028
6.4.3 France Latent TB Infection Testing Market Size, 2017-2028
6.4.4 U.K. Latent TB Infection Testing Market Size, 2017-2028
6.4.5 Italy Latent TB Infection Testing Market Size, 2017-2028
6.4.6 Russia Latent TB Infection Testing Market Size, 2017-2028
6.4.7 Nordic Countries Latent TB Infection Testing Market Size, 2017-2028
6.4.8 Benelux Latent TB Infection Testing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Latent TB Infection Testing Revenue, 2017-2028
6.5.2 China Latent TB Infection Testing Market Size, 2017-2028
6.5.3 Japan Latent TB Infection Testing Market Size, 2017-2028
6.5.4 South Korea Latent TB Infection Testing Market Size, 2017-2028
6.5.5 Southeast Asia Latent TB Infection Testing Market Size, 2017-2028
6.5.6 India Latent TB Infection Testing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Latent TB Infection Testing Revenue, 2017-2028
6.6.2 Brazil Latent TB Infection Testing Market Size, 2017-2028
6.6.3 Argentina Latent TB Infection Testing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Latent TB Infection Testing Revenue, 2017-2028
6.7.2 Turkey Latent TB Infection Testing Market Size, 2017-2028
6.7.3 Israel Latent TB Infection Testing Market Size, 2017-2028
6.7.4 Saudi Arabia Latent TB Infection Testing Market Size, 2017-2028
6.7.5 UAE Latent TB Infection Testing Market Size, 2017-2028
7 Players Profiles
7.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
7.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Corporate Summary
7.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
7.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Major Product Offerings
7.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Key News
7.2 Pharmstandard (Generium Pharmaceutical)
7.2.1 Pharmstandard (Generium Pharmaceutical) Corporate Summary
7.2.2 Pharmstandard (Generium Pharmaceutical) Business Overview
7.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Major Product Offerings
7.2.4 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.2.5 Pharmstandard (Generium Pharmaceutical) Key News
7.3 Sanofi S.A./Sanofi Pasteur Ltd.
7.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Corporate Summary
7.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
7.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Major Product Offerings
7.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Key News
7.4 Statens Serum Institut (SSI)
7.4.1 Statens Serum Institut (SSI) Corporate Summary
7.4.2 Statens Serum Institut (SSI) Business Overview
7.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Major Product Offerings
7.4.4 Statens Serum Institut (SSI) Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.4.5 Statens Serum Institut (SSI) Key News
7.5 Autoimmun Diagnostika (AID) GmbH
7.5.1 Autoimmun Diagnostika (AID) GmbH Corporate Summary
7.5.2 Autoimmun Diagnostika (AID) GmbH Business Overview
7.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Major Product Offerings
7.5.4 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.5.5 Autoimmun Diagnostika (AID) GmbH Key News
7.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
7.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Corporate Summary
7.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
7.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Major Product Offerings
7.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Key News
7.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
7.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Corporate Summary
7.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
7.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Major Product Offerings
7.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Key News
7.8 Immunoshop India Pvt. Ltd.
7.8.1 Immunoshop India Pvt. Ltd. Corporate Summary
7.8.2 Immunoshop India Pvt. Ltd. Business Overview
7.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Major Product Offerings
7.8.4 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.8.5 Immunoshop India Pvt. Ltd. Key News
7.9 Qiagen N.V.
7.9.1 Qiagen N.V. Corporate Summary
7.9.2 Qiagen N.V. Business Overview
7.9.3 Qiagen N.V. Latent TB Infection Testing Major Product Offerings
7.9.4 Qiagen N.V. Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.9.5 Qiagen N.V. Key News
7.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
7.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Corporate Summary
7.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
7.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Major Product Offerings
7.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Key News
7.11 SD Biosensor, Inc.
7.11.1 SD Biosensor, Inc. Corporate Summary
7.11.2 SD Biosensor, Inc. Business Overview
7.11.3 SD Biosensor, Inc. Latent TB Infection Testing Major Product Offerings
7.11.4 SD Biosensor, Inc. Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.11.5 SD Biosensor, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Latent TB Infection Testing Market Opportunities & Trends in Global Market
Table 2. Latent TB Infection Testing Market Drivers in Global Market
Table 3. Latent TB Infection Testing Market Restraints in Global Market
Table 4. Key Players of Latent TB Infection Testing in Global Market
Table 5. Top Latent TB Infection Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Latent TB Infection Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Latent TB Infection Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Latent TB Infection Testing Product Type
Table 9. List of Global Tier 1 Latent TB Infection Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Latent TB Infection Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Latent TB Infection Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Latent TB Infection Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Latent TB Infection Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Latent TB Infection Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Latent TB Infection Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Latent TB Infection Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Latent TB Infection Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Latent TB Infection Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Latent TB Infection Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Latent TB Infection Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Latent TB Infection Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Latent TB Infection Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Latent TB Infection Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Latent TB Infection Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Latent TB Infection Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Latent TB Infection Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Latent TB Infection Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Latent TB Infection Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Latent TB Infection Testing Revenue, (US$, Mn), 2023-2028
Table 30. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Corporate Summary
Table 31. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product Offerings
Table 32. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue (US$, Mn), (2017-2022)
Table 33. Pharmstandard (Generium Pharmaceutical) Corporate Summary
Table 34. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product Offerings
Table 35. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi S.A./Sanofi Pasteur Ltd. Corporate Summary
Table 37. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product Offerings
Table 38. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue (US$, Mn), (2017-2022)
Table 39. Statens Serum Institut (SSI) Corporate Summary
Table 40. Statens Serum Institut (SSI) Latent TB Infection Testing Product Offerings
Table 41. Statens Serum Institut (SSI) Latent TB Infection Testing Revenue (US$, Mn), (2017-2022)
Table 42. Autoimmun Diagnostika (AID) GmbH Corporate Summary
Table 43. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product Offerings
Table 44. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue (US$, Mn), (2017-2022)
Table 45. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Corporate Summary
Table 46. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product Offerings
Table 47. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue (US$, Mn), (2017-2022)
Table 48. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Corporate Summary
Table 49. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product Offerings
Table 50. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue (US$, Mn), (2017-2022)
Table 51. Immunoshop India Pvt. Ltd. Corporate Summary
Table 52. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product Offerings
Table 53. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue (US$, Mn), (2017-2022)
Table 54. Qiagen N.V. Corporate Summary
Table 55. Qiagen N.V. Latent TB Infection Testing Product Offerings
Table 56. Qiagen N.V. Latent TB Infection Testing Revenue (US$, Mn), (2017-2022)
Table 57. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Corporate Summary
Table 58. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product Offerings
Table 59. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue (US$, Mn), (2017-2022)
Table 60. SD Biosensor, Inc. Corporate Summary
Table 61. SD Biosensor, Inc. Latent TB Infection Testing Product Offerings
Table 62. SD Biosensor, Inc. Latent TB Infection Testing Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Latent TB Infection Testing Segment by Type in 2021
Figure 2. Latent TB Infection Testing Segment by Application in 2021
Figure 3. Global Latent TB Infection Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Latent TB Infection Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Latent TB Infection Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Latent TB Infection Testing Revenue in 2021
Figure 8. By Type - Global Latent TB Infection Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Latent TB Infection Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Latent TB Infection Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Latent TB Infection Testing Revenue Market Share, 2017-2028
Figure 12. US Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Latent TB Infection Testing Revenue Market Share, 2017-2028
Figure 16. Germany Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Latent TB Infection Testing Revenue Market Share, 2017-2028
Figure 24. China Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Latent TB Infection Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Latent TB Infection Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Latent TB Infection Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Statens Serum Institut (SSI) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Qiagen N.V. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. SD Biosensor, Inc. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
